Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1CNS 1

Conditions

Other Cancer 1Neoplasms 1Gastrointestinal Neoplasms 1Brain Neoplasms 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Advance Care Planning × Clear all
NCT07174661 2025-12-18

Educational Tools for the Improvement of Early Advance Care Planning in Adolescents and Young Adults With Advanced Solid Tumors and High-Grade Brain Tumors

Mayo Clinic

Phase NA Recruiting
50 enrolled
CNS

Brain Neoplasms

NCT03609177 2025-10-21

ACP-PEACE

Dana-Farber Cancer Institute

Phase NA Completed
13,800 enrolled 15 charts

Other Cancer

NCT03676426 2020-05-07

Comparison of a Web-based Advance Directive to a Standard Advance Directive

University of Pennsylvania

Phase NA Completed
90 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

NCT01670461 2019-03-08

FACE

Children's National Research Institute

Phase NA Completed
60 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡